BACKGROUND: Heart failure after myocardial infarction (MI) is a result of increased myocardial workload, adverse left ventricular (LV) geometric remodeling, and less efficient LV fluid movement. In this study we utilize cardiac magnetic resonance imaging to evaluate ventricular function and flow after placement of a novel directed epicardial assist device. METHODS: Five swine underwent posterolateral MI and were allowed to remodel for 12 weeks. An inflatable bladder was positioned centrally within the infarct and secured with mesh. The device was connected to an external gas exchange pump, which inflated and deflated in synchrony with the cardiac cycle. Animals then underwent cardiac magnetic resonance imaging during active epicardial assistance and with no assistance. RESULTS: Active epicardial assistance of the infarct showed immediate improvement in LV function and intraventricular flow. Ejection fraction significantly improved from 26.0% ± 4.9% to 37.3% ± 4.5% (p < 0.01). End-systolic volume (85.5 ± 12.7 mL versus 70.1 ± 11.9 mL, p < 0.01) and stroke volume (28.5 ± 4.4 mL versus 39.9 ± 3.1 mL, p = 0.03) were also improved with assistance. End-diastolic volume and regurgitant fraction did not change with treatment. Regional LV flow improved both qualitatively and quantitatively during assistance. Unassisted infarct regional flow showed highly discoordinate blood movement with very slow egress from the posterolateral wall. Large areas of stagnant flow were also identified. With assistance, posterolateral wall blood velocities improved significantly during both systole (26.4% ± 3.2% versus 12.6% ± 1.2% maximum velocity; p < 0.001) and diastole (54.3% ± 9.3% versus 24.2% ± 2.5% maximum velocity; p < 0.01). CONCLUSIONS: Directed epicardial assistance can improve LV function and flow in ischemic cardiomyopathy. This novel device may provide a valuable alternative to currently available heart failure therapies.
BACKGROUND:Heart failure after myocardial infarction (MI) is a result of increased myocardial workload, adverse left ventricular (LV) geometric remodeling, and less efficient LV fluid movement. In this study we utilize cardiac magnetic resonance imaging to evaluate ventricular function and flow after placement of a novel directed epicardial assist device. METHODS: Five swine underwent posterolateral MI and were allowed to remodel for 12 weeks. An inflatable bladder was positioned centrally within the infarct and secured with mesh. The device was connected to an external gas exchange pump, which inflated and deflated in synchrony with the cardiac cycle. Animals then underwent cardiac magnetic resonance imaging during active epicardial assistance and with no assistance. RESULTS: Active epicardial assistance of the infarct showed immediate improvement in LV function and intraventricular flow. Ejection fraction significantly improved from 26.0% ± 4.9% to 37.3% ± 4.5% (p < 0.01). End-systolic volume (85.5 ± 12.7 mL versus 70.1 ± 11.9 mL, p < 0.01) and stroke volume (28.5 ± 4.4 mL versus 39.9 ± 3.1 mL, p = 0.03) were also improved with assistance. End-diastolic volume and regurgitant fraction did not change with treatment. Regional LV flow improved both qualitatively and quantitatively during assistance. Unassisted infarct regional flow showed highly discoordinate blood movement with very slow egress from the posterolateral wall. Large areas of stagnant flow were also identified. With assistance, posterolateral wall blood velocities improved significantly during both systole (26.4% ± 3.2% versus 12.6% ± 1.2% maximum velocity; p < 0.001) and diastole (54.3% ± 9.3% versus 24.2% ± 2.5% maximum velocity; p < 0.01). CONCLUSIONS: Directed epicardial assistance can improve LV function and flow in ischemic cardiomyopathy. This novel device may provide a valuable alternative to currently available heart failure therapies.
Authors: Andrew H Goldstein; Gretel Monreal; Atsushi Kambara; Allison J Spiwak; Matthew L Schlossberg; A Reza Abrishamchian; Mark A Gerhardt Journal: J Card Fail Date: 2005-03 Impact factor: 5.712
Authors: Yoshiharu Enomoto; Joseph H Gorman; Sina L Moainie; Benjamin M Jackson; Landi M Parish; Theodore Plappert; Ahmad Zeeshan; Martin G St John-Sutton; Robert C Gorman Journal: Ann Thorac Surg Date: 2005-03 Impact factor: 4.330
Authors: Morteza Gharib; Edmond Rambod; Arash Kheradvar; David J Sahn; John O Dabiri Journal: Proc Natl Acad Sci U S A Date: 2006-04-10 Impact factor: 11.205
Authors: Ravi K Ghanta; Aravind Rangaraj; Ramanan Umakanthan; Lawrence Lee; Rita G Laurence; John A Fox; R Morton Bolman; Lawrence H Cohn; Frederick Y Chen Journal: Circulation Date: 2007-03-05 Impact factor: 29.690
Authors: Ann F Bolger; Einar Heiberg; Matts Karlsson; Lars Wigström; Jan Engvall; Andreas Sigfridsson; Tino Ebbers; John-Peder Escobar Kvitting; Carl Johan Carlhäll; Bengt Wranne Journal: J Cardiovasc Magn Reson Date: 2007 Impact factor: 5.364
Authors: Jeremy R McGarvey; Norihiro Kondo; Walter R T Witschey; Manabu Takebe; Chikashi Aoki; Jason A Burdick; Francis G Spinale; Joseph H Gorman; James J Pilla; Robert C Gorman Journal: Ann Thorac Surg Date: 2014-12-15 Impact factor: 4.330